Completed PHASE4 INTERVENTIONAL 2-arm NCT00901628

Periarticular Multimodal Drug Injections in Total Knee Arthroplasty

Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty

Sponsor: Seoul National University Hospital

Interventions cefuroxime epinephrine ketorolac morphine sulfate ropivacaine

Updated 6 times since 2017 Last updated: Dec 15, 2012 Started: Apr 30, 2008 Primary completion: Mar 31, 2009 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00901628, this PHASE4 trial focuses on Osteoarthritis, Knee and remains completed. Sponsored by Seoul National University Hospital, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seongnam-si, South Korea